APOE, apolipoprotein E, 348

N. diseases: 1049; N. variants: 62
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE The aim of this study was to investigate the effects of HS and GP tea consumption on anthropometric data, fasting blood glucose (FBG), and lipid concentrations in hypercholesterolemia subjects with different genotypes of the APOE and CETP TaqIB polymorphisms. 28244718 2017
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE APOE-e4 associated with a higher likelihood of hypercholesterolemia and overall illness index scores (ps < .05). 27486898 2016
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE Here, we test whether hypercholesterolemia (HC) and ApoE polymorphisms affect the risk of ICH by statin use. 24008570 2013
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE We analyzed whether low birth weight and apolipoprotein E (Apo E) polymorphism participate in the onset of hypercholesterolemia in children. 18052682 2008
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE Other murine models target genes relevant to AMD, including inflammatory genes such as Cfh(-/-), Ccl2(-/-), Ccr2(-/-), Cx3cr1(-/-), and Ccl2(-/-)/cx3cr1(-/-), oxidative stress associated genes such as Sod1(-/-) and Sod2 knockdown, metabolic pathway genes such as neprilysin(-/-) (amyloid beta), transgenic mcd/mcd (cathepsin D), Cp(-/-)/Heph(-/Y) (ferroxidase ceruloplasmin/hepaestin, iron metabolism), and transgenic ApoE4 on high fat and high cholesterol diet (lipid metabolism). 20206286 2010
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE APOE ε4 allele is an established risk factor for Alzheimer's disease and hypercholesterolemia. 31677348 2019
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE Therefore, the effects of diet-induced hypercholesterolemia on cardiac function and remodeling were investigated up to eight weeks after myocardial ischemia-reperfusion (MI-R) injury which was induced in either normocholesterolemic (NC-MI) or hypercholesterolemic (HC-MI) APOE*3-Leiden mice. 31199833 2019
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE Apolipoprotein-E/galectin-3 knockout mice were generated and fed a high-cholesterol "western" diet. 23426722 2013
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE Hypercholesterolemia with statin use was associated with less risk of ICH (OR=0.30; P=0.0008) in multivariable analysis after controlling for alcohol use, hypertension, previous stroke, first-degree relative with ICH, education level, and apolipoprotein E alleles. 15087556 2004
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE We investigated the effect of perinatal hypercholesterolemia on the atherosclerosis development in the offspring of apolipoprotein E-deficient mice and the underlying mechanism. 28935756 2017
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 AlteredExpression disease BEFREE Gestational hypercholesterolemia alters fetal hepatic lipid metabolism and microRNA expression in Apo-E-deficient mice. 31453710 2019
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE RESULTS APOE was significantly associated with hypercholesterolaemia (epsilon4 72% vs. epsilon3 66% vs. epsilon2 51%; P < 0.0001), and premature MI (epsilon4 57% vs. epsilon3 50% vs. epsilon2 41%; P < 0.0001; hazard ratio 1.41, 95%CI 1.14-1.75). 17217375 2007
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE In addition to our previous finding, this study indicates that hypercholesterolemia in apoE4-carrying NIDDM patients may be more closely related to poor metabolic control and increased percentage of ideal body weight. 2060414 1991
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE We established a novel atherosclerosis-susceptible mouse model with both severe HHcy and hypercholesterolemia in which the mouse cystathionine beta-synthase (CBS) and apolipoprotein E (apoE) genes are deficient and an inducible human CBS transgene is introduced to circumvent the neonatal lethality of the CBS deficiency (Tg-hCBS apoE(-/-) Cbs(-/-) mice). 19858416 2009
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE So far the major findings have included: apolipoprotein E e4, a major risk factor for AD in most populations, is also a risk factor for AD in African Americans but not for Yoruba; African Americans are at higher risk not only for AD, but also for diseases associated with increased cardiovascular risk such as hypertension, diabetes, and metabolic syndrome; African Americans have higher rates of hypercholesterolemia than Yoruba: there is an interaction between apolipoprotein E e4, cholesterol, and AD risk in both Yoruba and African Americans. 16917194 2006
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE To examine a long-term effect of community-based education program for hypercholesterolemia and an effect modification by apolipoprotein E polymorphism, we conducted a 1-year randomized clinical trial with 8 year-follow-up. 12119210 2002
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE The relation of hypercholesterolemia and apolipoprotein E (ApoE) to cerebral aneurysm formation, has been unclear until now. 18360691 2008
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE APOE genotypes were not associated with hypercholesterolemia. 30457419 2019
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE The interaction effect between APOE genotype and hypercholesterolemia was statistically significant in both cohorts. 26495840 2016
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE To characterize their effect on atherogenesis, APOE*3Leiden.CETP mice were fed a high cholesterol/high fat diet (WTD) or normal chow (NC) for 18 weeks. 31366894 2019
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE Hypercholesterolemia-Induced Loss of Flow-Induced Vasodilation and Lesion Formation in Apolipoprotein E-Deficient Mice Critically Depend on Inwardly Rectifying K<sup>+</sup> Channels. 29502106 2018
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE The combination of APOE epsilon4 with hypercholesterolemia or diabetes showed the greatest cognitive decline. 15668424 2005
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE We maintained apolipoprotein E-deficient mice on a high cholesterol diet and induced myocardial infarction by transient ligation at 4 weeks. 28397162 2017
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 Biomarker disease BEFREE In this study, we evaluated the influence of aging and hypercholesterolemia on serum pro-inflammatory cytokines, oxidative stress, DNA damage and apoptosis in monocytes from apolipoprotein E-deficient (apoE<sup>-/-</sup>) mice compared with age-matched wild-type C57BL/6 (WT) mice. 30185234 2018
CUI: C0020443
Disease: Hypercholesterolemia
Hypercholesterolemia
0.700 GeneticVariation disease BEFREE Effect of apolipoprotein E polymorphism on the serum lipid response to a hypolipidemic diet rich in monounsaturated fatty acids in patients with hypercholesterolemia and combined hyperlipidemia. 7825526 1995